Abstract
We report a treatment failure to azithromycin 2.0 g caused by a urethral Neisseria gonorrhoeae isolate with high-level azithromycin resistance in California. This report describes the epidemiological case investigation and phenotypic and genetic characterization of the treatment failure isolate.
MeSH terms
-
Adult
-
Anti-Bacterial Agents / administration & dosage*
-
Azithromycin / pharmacology*
-
California / epidemiology
-
Ceftriaxone / administration & dosage*
-
Contact Tracing
-
Drug Resistance, Bacterial
-
Female
-
Gonorrhea / drug therapy*
-
Gonorrhea / genetics
-
Gonorrhea / microbiology
-
Humans
-
Male
-
Microbial Sensitivity Tests
-
Neisseria gonorrhoeae / drug effects*
-
Neisseria gonorrhoeae / genetics
-
Population Surveillance
-
Treatment Failure
-
United States / epidemiology
-
Urethritis / drug therapy*
-
Urethritis / etiology
-
Urethritis / genetics
Substances
-
Anti-Bacterial Agents
-
Ceftriaxone
-
Azithromycin